
Catalyst Biosciences CBIO
$ 11.66
-8.95%
Quarterly report 2025-Q3
added 11-07-2025
Catalyst Biosciences PEG Ratio 2011-2026 | CBIO
Annual PEG Ratio Catalyst Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00243 | -0.109 | 0.0152 | -0.0611 | 0.0228 | -0.0498 | -0.0514 | -0.00696 | -0.013 | -0.0639 | 0.0043 | -0.71 | 0.0971 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.0971 | -0.71 | -0.071 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Biogen
BIIB
|
-1.57 | $ 173.17 | 0.92 % | $ 25.2 B | ||
|
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M | ||
|
Acorda Therapeutics
ACOR
|
-0.000047 | - | -24.86 % | $ 820 K | ||
|
BioNTech SE
BNTX
|
-12.8 | $ 117.62 | 1.41 % | $ 27.2 B | ||
|
Aptorum Group Limited
APM
|
0.0951 | $ 0.98 | 1.35 % | $ 5.34 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-0.0509 | $ 3.67 | 3.38 % | $ 8.83 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | ||
|
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | ||
|
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | ||
|
BioXcel Therapeutics
BTAI
|
-0.000279 | $ 1.77 | -2.75 % | $ 4.49 M | ||
|
BioLineRx Ltd.
BLRX
|
1.32 | $ 3.12 | 0.59 % | $ 908 M | ||
|
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | ||
|
Cellectis S.A.
CLLS
|
0.00224 | $ 4.13 | -6.56 % | $ 116 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
-0.767 | $ 233.49 | -0.81 % | $ 5 B | ||
|
Burford Capital Limited
BUR
|
-0.568 | $ 9.71 | -0.46 % | $ 1.57 B | ||
|
ARCA biopharma
ABIO
|
-0.0372 | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
-0.0483 | - | 4.01 % | $ 150 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
-141 | $ 67.41 | 0.54 % | $ 9.02 B | ||
|
Compugen Ltd.
CGEN
|
0.0951 | $ 2.04 | -2.39 % | $ 183 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
6.6 | $ 4.36 | -2.46 % | $ 9.49 B | ||
|
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | ||
|
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-0.00126 | - | -15.15 % | $ 60.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
0.0954 | $ 26.57 | 2.51 % | $ 1.29 B | ||
|
Coherus BioSciences
CHRS
|
0.0108 | $ 2.26 | 9.7 % | $ 213 M | ||
|
Amneal Pharmaceuticals
AMRX
|
0.0622 | $ 13.59 | 1.46 % | $ 4.2 B | ||
|
AIkido Pharma
AIKI
|
-0.000777 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
-2.41 | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | ||
|
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | ||
|
Acer Therapeutics
ACER
|
0.0443 | - | 2.71 % | $ 14 M | ||
|
Aravive
ARAV
|
0.0342 | - | -13.39 % | $ 1.45 M | ||
|
Alpine Immune Sciences
ALPN
|
4.18 | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | ||
|
Athira Pharma
ATHA
|
0.0276 | - | - | $ 269 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.000293 | - | -11.43 % | $ 502 K | ||
|
Celldex Therapeutics
CLDX
|
-0.000001 | $ 26.72 | 3.09 % | $ 1.72 M | ||
|
AVROBIO
AVRO
|
0.068 | - | 1083.1 % | $ 745 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-0.00324 | $ 2.75 | 1.85 % | $ 17.3 M | ||
|
AstraZeneca PLC
AZN
|
-369 | $ 94.24 | 1.38 % | $ 96.9 B | ||
|
Arena Pharmaceuticals
ARNA
|
0.0469 | - | -6.81 % | $ 3.04 B | ||
|
Brickell Biotech
BBI
|
-0.00369 | - | -5.38 % | $ 6.06 M |